Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history now shows a new entry for Revision: v3.6.4, updating the page's revision metadata from v3.6.3.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history now includes a new version entry for v3.6.3 and removes the previous v3.6.2 entry, signaling an updated revision of the study record. This update documents the latest revision in the history.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed. This reflects an update to the documentation of the page's history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now shows explicit 'Last verified' and 'Last known status was' with a new 'Revision: v3.6.0', replacing the previous labels and the older revision 'v3.5.5'.SummaryDifference3%

- Check60 days agoChange DetectedThe study history shows a new revision entry (v3.5.5) and the previous revision (v3.5.4) is removed from the history list, updating the visible record of changes.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a new Revision: v3.5.4 entry to the Study Record History, replacing the previous Revision: v3.5.3 entry and indicating an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.